November 6 - 8, 2026

St. Regis San Francisco 
125 3rd Street, San Francisco CA 94103
 

Course Chairs

Uma Mahadevan, MD
Lynne and Marc Benioff Professor of Gastroenterology,
Director, UCSF Colitis and Crohn’s Disease Center

Rishika Chugh, MD
Assistant Professor of Medicine, University of California, San Francisco 
Division of Gastroenterology

Fernando Velayos, MD, MPH
Professor of Medicine, University of California, San Francisco 
Director of Inflammatory Bowel Disease, Northern California Kaiser

Overview

The UCSF Colitis and Crohn’s Disease Center is dedicated to providing comprehensive care for individuals with Crohn's disease, ulcerative colitis, and related illnesses. As part of this commitment, we are proud to present our twentieth inflammatory bowel disease (IBD) symposium. This course will address advances in the medical and surgical management of Crohn's disease and ulcerative colitis including novel therapies and optimizing current medications. Management of special populations including the pregnant patient and those with complications of therapy will be discussed. This year’s course also includes a workshop on Intestinal Ultrasound for IBD.

Who Should Attend This Course?
This symposium is designed for gastroenterologists, colorectal surgeons, internists, and other health professionals who participate in the management of this complicated patient population.

Objectives

Upon completion of this course, attendees will refine their approaches to:

  • Select appropriate evidence-based therapeutic strategies and monitoring approaches for patients with Crohn's disease and ulcerative colitis.
  • Identify and evaluate emerging therapeutic mechanisms and treatment options for inflammatory bowel disease (IBD).
  • Apply current evidence-based recommendations for the diagnosis and management ofClostridioides difficile infection in patients with IBD.
  • Assess age-related clinical considerations and individualize treatment strategies for older adults with IBD.
  • Critically evaluate the available evidence, potential benefits, limitations, and clinical applicability of functional medicine approaches and hyperbaric oxygen therapy in the management of IBD.
  • Identify and implement strategies to reduce low-value care and optimize evidence-based management of patients with IBD.